Object: Alzheimer's disease is a progressive, irreversible neurodegenerative disorder associated with brain alterations. Diffusion tensor imaging (DTI) has contributed to identify degeneration in white matter cortical microstructural that can be considered an early and specific biomarker for Alzheimer's disease. This review aimed to provide a summary of DTI studies on white matter damage in Alzheimer's disease. Methods: On PubMed, Web of Science and Scopus databases, we reviewed the studies that used DTI for assessing fractional anisotropy in neurofiber tracts involved in Alzheimer's Disease progression: fornix, the cingulum, uncinate fasciculus, superior and inferior longitudinal fasciculus and corpus callosum. We included nine studies that met search criteria. Results: The results showed decreased fractional anisotropy value in mild cognitive impairment (MCI) patients. White matter diffusivity changes were associated with the progression of Alzheimer's disease. Conclusion: Microstructural alterations of the limbic and cortico-cortical tracts could be potential biomarkers for early diagnosis in preclinical disease phase.
Object: Alzheimer's disease is a progressive, irreversible neurodegenerative disorder associated with brain alterations. Diffusion tensor imaging (DTI) has contributed to identify degeneration in white matter cortical microstructural that can be considered an early and specific biomarker for Alzheimer's disease. This review aimed to provide a summary of DTI studies on white matter damage in Alzheimer's disease. Methods: On PubMed, Web of Science and Scopus databases, we reviewed the studies that used DTI for assessing fractional anisotropy in neurofiber tracts involved in Alzheimer's Disease progression: fornix, the cingulum, uncinate fasciculus, superior and inferior longitudinal fasciculus and corpus callosum. We included nine studies that met search criteria. Results: The results showed decreased fractional anisotropy value in mild cognitive impairment (MCI) patients. White matter diffusivity changes were associated with the progression of Alzheimer's disease. Conclusion: Microstructural alterations of the limbic and cortico-cortical tracts could be potential biomarkers for early diagnosis in preclinical disease phase.
Authors: Negar Fani; Nathaniel G Harnett; Bekh Bradley; Yara Mekawi; Abigail Powers; Jennifer S Stevens; Kerry J Ressler; Sierra E Carter Journal: Biol Psychiatry Date: 2021-08-24 Impact factor: 13.382
Authors: Brendan Miller; Su-Jeong Kim; Hemal H Mehta; Kevin Cao; Hiroshi Kumagai; Neehar Thumaty; Naphada Leelaprachakul; Henry Jiao; Joan Vaughan; Jolene Diedrich; Alan Saghatelian; Thalida E Arpawong; Eileen M Crimmins; Nilüfer Ertekin-Taner; Meral A Tubi; Evan T Hare; Meredith N Braskie; Léa Décarie-Spain; Scott E Kanoski; Francine Grodstein; David A Bennett; Lu Zhao; Arthur W Toga; Junxiang Wan; Kelvin Yen; Pinchas Cohen Journal: Mol Psychiatry Date: 2022-09-21 Impact factor: 13.437
Authors: Maurizio Bergamino; Elizabeth G Keeling; Leslie C Baxter; Nicholas J Sisco; Ryan R Walsh; Ashley M Stokes Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Nabil Ettehadi; Pratik Kashyap; Xuzhe Zhang; Yun Wang; David Semanek; Karan Desai; Jia Guo; Jonathan Posner; Andrew F Laine Journal: Front Hum Neurosci Date: 2022-03-30 Impact factor: 3.473
Authors: Lyduine E Collij; Silvia Ingala; Herwin Top; Viktor Wottschel; Kristine E Stickney; Jori Tomassen; Elles Konijnenberg; Mara Ten Kate; Carole Sudre; Isadora Lopes Alves; Maqsood M Yaqub; Alle Meije Wink; Dennis Van 't Ent; Philip Scheltens; Bart N M van Berckel; Pieter Jelle Visser; Frederik Barkhof; Anouk Den Braber Journal: Alzheimers Dement (Amst) Date: 2021-04-01